During a live event in the Oval Office focused on drug prices, Novo Nordisk executive Gordon Findlay unexpectedly fainted next to President Donald Trump. The press was quickly asked to leave, and officials immediately provided medical assistance.
The White House confirmed that Findlay had fainted but reassured the public that he was “OK.”
This incident has intensified the ongoing conversation about the challenges facing the American healthcare system, particularly the rising cost of medications.
“Findlay had fainted and was ‘OK,’” the White House said.
Such unexpected moments highlight the pressure surrounding the healthcare crisis and drug pricing issues in the U.S.
Summary: Gordon Findlay’s fainting during President Trump’s drug price announcement underscores the intense spotlight on America's rising medication costs and healthcare challenges.